Medlab Clinical (ASX:MDC) - CEO, Dr Sean Hall - The Market Herald

" Medlab Clinical (ASX:MDC) completes NRGBiotic trial

Medlab Clinical (MDC) has completed the intervention stage of the Queensland University of Technology (QUT) depression trial using the NRGBiotic product.
Bod Australia (ASX:BDA)- CEO, Jo Patterson - The Market Herald

" Bod Australia (ASX:BDA) receives R&D tax refund of $851k

Medicinal cannabis company Bod Australia (BDA) has received an $851,000 research & development (R&D) tax refund.
Fiji Kava (ASX:FIJ) - Managing Director & CEO, Zane Yoshida - The Market Herald

" Fiji Kava (ASX:FIJ) reduces remuneration and board fees due to COVID-19

Health and wellness company, Fiji Kava (FIJ) has put in precautionary measures and protocols due to the coronavirus (COVID-19).
Creso Pharma (ASX:CPH) - Co founder, CEO & Executive Director, Dr Miri Halperin Wernli - The Market Herald

" Creso Pharma’s (ASX:CPH) subsidiary receives C$775K order from Israel

Creso Pharma’s (CPH) subsidiary, Mernova Medicinal, has received a CA$775,000 purchase order for its medicinal cannabis flower from Univo Pharmaceuticals.
Genetic Technologies (ASX:GTG) to provide risk assessment tests directly to consumers

" Genetic Technologies (ASX:GTG) to provide risk assessment tests directly to consumers

Predictive testing specialist Genetic Technologies (GTG) has fast-tracked the launch of its Consumer Initiated Testing platform in light of the COVID-19 crisis.
Alcidion Group (ASX:ALC) - Gropu Managing Director, Kate Quirke - The Market Herald

" Alcidion Group (ASX:ALC) renews longstanding NHS Fife partnership

Healthcare tech specialist Alcidion (ALC) has renewed a contract with NHS Fife for its Patientrack patient monitoring product.
OncoSil Medical (ASX:OSL) - Managing Director & CEO, Daniel Kenny - The Market Herald

" OncoSil Medical’s (ASX:OSL) breakthrough device receives CE Marking approval

Australian medtech OncoSil Medical (OSL) has announced its OncoSil device has received European CE Marking approval.
ResApp Health (ASX:RAP) - CEO & Managing Director, Tony Keating - The Market Herald

" ResApp Health (ASX:RAP) to launch OSA screening app, SleepCheck

ResApp Health (RAP) will soon launch SleepCheck, an at-home obstructive sleep apnoea (OSA) screening smartphone app.
AusCann (ASX:AC8) - CEO, Ido Kanyon - The Market Herald

" AusCann (ASX:AC8) ready to begin first clinical evaluation of hard-shell capsules

Medicinal cannabis company AusCann (AC8) is ready to start its first clinical evaluation of its hard-shell capsules.
ImpediMed (ASX:IPD) - CEO, Rick Carreon - The Market Herald

" ImpediMed (ASX:IPD) receives first orders under Lymphodema Prevention Program

Medical imaging company ImpediMed (IPD) has received its first batch of orders from its recently-announced U.S. purchasing agreement.